Epstein-Barr virus seroepidemiology in China

Zeng, Y. and Pi, G. H. and Deng, H. and Zhang, J. M. and Wang, P. C. and Wolf, Hans J. and De Thé, G. (1986) Epstein-Barr virus seroepidemiology in China. AIDS research 2, Suppl. 1, S7-S15.

Full text not available from this repository.

Abstract

Since 1978 more than 300,000 sera from normal individuals were screened serologically in NPC high risk areas and prospective studies were carried out. Many patients were diagnosed in early stage. For example, in Wuzhou city, 20,726 persons over 40 years of age were screened; 1,138 persons were found to have IgA VCA antibody. Among them 18 NPC cases were detected; an additional 21 NPC patients were found within 5 year follow-up studies. Altogether there were 39 NPC patients. As compared to the patients in outpatient clinics, the frequency of NPC in stage I increased from 1.7% to 38.5% and in early stage (I + II) increased from 32% to 92.3%. IgA VCA antibody can be detected 5 years before the diagnosis of NPC in early stage was made. The detection rate of NPC from IgA VCA antibody-positive persons is 38-374 times the incidence rate of NPC in the general population of the same age group. Follow-up studies on the change of IgA VCA antibody titer in antibody-positive and antibody-negative groups were also carried out for years. 10.9% of antibody-positive individuals became antibody negative and 5.4% seronegative persons converted to positive within 4 years. Eighty-eight per cent of NPC patients were detected in the group of no change of antibody titer or in the group of increasing antibody titer. No NPC patients were found in the original antibody negative group.

Item Type:Article
Institutions: Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene
Identification Number:
ValueType
3030349PubMed ID
Classification:
NotationType
Antibodies, Viral/analysisMESH
Antigens, Viral/immunologyMESH
Capsid ProteinsMESH
Carcinoma/prevention & controlMESH
ChinaMESH
Enzyme-Linked Immunosorbent AssayMESH
Follow-Up StudiesMESH
Herpesvirus 4, Human/immunologyMESH
HumansMESH
Immunoglobulin A/analysisMESH
Mass ScreeningMESH
Nasopharyngeal Neoplasms/prevention & controlMESH
RiskMESH
Tumor Virus Infections/immunologyMESH
Subjects:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Unknown
Created at the University of Regensburg:Unknown
Owner:Gertraud Kellers
Deposited On:18 Apr 2011 13:34
Last Modified:19 May 2011 11:45
Item ID:20550
Owner Only: item control page